Price movement over the last 24 hours
Samcro Hyosung Adilestari Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Samcro Hyosung Adilestari Tbk. trades at Rp60 (market cap 208.16B, 9.55M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Samcro Hyosung Adilestari Tbk. is the larger of the two by market cap, and Samcro Hyosung Adilestari Tbk. is more actively traded (9.55M versus 2.51M). Which is the better fit depends on your goals.
| ACRO | OBAT | |
|---|---|---|
Market Cap | 208.16B | 160.57B |
Volume | 9.55M | 2.51M |
Lot | 95.5K | 25.09K |
Turnover | 587.56M | 636.74M |
Average Price | 61.52 | 253.78 |
Value | 587.56M | 636.74M |
Indicative Equilibrium Price | 60 | 242 |
Indicative Equilibrium Volume | 2K | 146 |
Trailing returns across standard periods
Latest headlines on both assets
PT Samcro Hyosung Adilestari Tbk (The Company) was established on Republic of Indonesia based on Deed of Establishment No. 265 dated July 21, 1989 by Yudo Paripurno, S.H., Notary in Jakarta.
Read more on ACRO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →